Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
D000328:Adult; D001219:Aspartate Aminotransferases / Q000097:blood; D002762:Cholecalciferol / Q000008:administration & dosage / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D004100:Dihydroxycholecalciferols / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006934:Hypercalcemia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D002762:Cholecalciferol; D001219:Aspartate Aminotransferases